Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
06/2002
06/27/2002DE10063115A1 Triazolopyrimidine Triazolopyrimidines
06/27/2002CA2432417A1 Cyclin-dependent kinase (cdk) and glycolene synthase kinase-3 (gsk-3) inhibitors
06/27/2002CA2431965A1 Novel substituted imidazotriazinones as pde ii-inhibitors
06/27/2002CA2431077A1 Pharmaceutical formulation comprising pyrazolo[4,3-d]pyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives
06/26/2002EP1216248A2 Triazolopyrimidine derivatives
06/26/2002EP1216247A1 Imidazoimidazoles and triazoles as anti-inflammatory agents
06/26/2002EP1216246A1 N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
06/26/2002EP1216231A2 INHIBITORS OF FACTOR Xa
06/26/2002EP1216230A2 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists
06/26/2002EP1216228A2 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
06/26/2002EP1216045A2 Vasopressin agonist formulation and process
06/26/2002CN1355806A Process for preparation of herbicidal derivatives
06/26/2002CN1355803A Cucurbiturils and method for synthesis
06/26/2002CN1355802A Substituted porphyrins
06/26/2002CN1355713A Releasable bond and composition containing said bond
06/26/2002CN1086722C Pigment compositions of diketopyrrolopyrroles
06/26/2002CN1086696C Sulphonylamino (thio) carbonyl compounds
06/25/2002US6410788 Process to produce oxazolidinones
06/25/2002US6410747 Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias
06/25/2002US6410628 Photoactivatable nitrogen-containing bases based on alpha-amino ketones
06/25/2002US6410568 Porphyrins and their use as photosensitizer
06/25/2002US6410566 Cyclic amine derivatives and their use as drugs
06/25/2002US6410497 Detergents; bleaches; antiseptics
06/25/2002US6410480 Plant safening agents and growth regulators for controlling weeds and grasses; post/preemergence herbicides
06/25/2002US6409956 Partially crystalline plastics
06/20/2002WO2002048154A2 Cobalt-porphyrin complexes and use thereof as an anti-obesity agent
06/20/2002WO2002048152A2 Spiro[isobenzofuran-1,4'-piperidin]-3-ones and 3h-spiroisobenzofuran-1,4'-piperidines
06/20/2002WO2002048151A1 6-phenyl-pyrazolopyrimidines
06/20/2002WO2002048150A2 Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof
06/20/2002WO2002048146A2 Use of substituted imidazoazines, novel imidazoazines, methods for the production thereof, and agents containing these compounds
06/20/2002WO2002048117A1 Quinazolinone derivatives
06/20/2002WO2002048116A2 Inhibitors of hepatitis c virus ns3 protease
06/20/2002WO2002047722A1 Medicinal compositions of nonpeptidyl gonadotropin-releasing hormone agonist or antagonist, process for producing the same and use thereof
06/20/2002WO2002047679A2 Nonpeptide agonists and antagonists of vasopressin receptors
06/20/2002WO2002047671A2 Lactam compound to inhibit beta-amyloid peptide release or synthesis
06/20/2002WO2002020495A3 Inhibitors of glycogen synthase kinase 3
06/20/2002WO2002012243A3 SYNTHESIS OF (R)-3-(4-BROMOBENZYL)-1-(3,5-DICHLOROPHENYL)-5-IODO-3-METHYL-1-H-IMIDAZO[1,2-a]IMIDAZOL-2-ONE
06/20/2002WO2002012214A3 Non-imidazole aryloxyalkylamines as h3 receptor ligands
06/20/2002WO2002011732A8 Novel bicyclic and tricyclic pyrrolidine derivatives as gnrh antagonists
06/20/2002WO2001083448A3 Novel prodrugs von 6-hydroxy-2,3-dihydro-1h-indoles, 5-hydroxy-1,2-dihydro-3h-pyrrolo[3,2-e]indoles and 5-hydroxy-1,2-dihydro-3h-benzo(e)indoles as well as of 6-hydroxy-1,2,3,4-tetrahydro-benzo[f]quinoline derivatives for use in selective cancer therapy
06/20/2002US20020077503 Used to prepare one-pot systems with base-catalysable oligomers or monomers having storage stability; catalysts
06/20/2002US20020077486 Platelet ADP receptor inhibitors
06/20/2002US20020077346 For therapy of inflammatory and pain of a traumatic or pathologic origin
06/20/2002US20020077337 Chemical compounds
06/20/2002US20020077327 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
06/20/2002US20020077318 Substituted azepino[4,5b] indoline derivatives
06/20/2002US20020076664 Silver halide color photographic light-sensitive material, pyrrolotriazole compound, and dye-forming compound
06/20/2002US20020076648 Optical data medium containing, in the information layer, a phthalocyanine dye as a light-absorbing compound
06/20/2002DE10063108A1 Verfahren zur Herstellung von Sulfonamid-substituierten Imidazotriazinonen A process for producing sulfonamide-substituted imidazotriazinones
06/20/2002DE10063106A1 Verfahren zur Herstellung von 2-(2-Ethoxyphenyl)-substituierten Imidazotriazinonen A process for the preparation of 2- (2-ethoxyphenyl) substituted imidazotriazinones
06/20/2002CA2432825A1 Nonpeptide agonists and antagonists of vasopressin receptors
06/20/2002CA2431663A1 Cobalt-porphyrin complexes and use thereof as an anti-obesity agent
06/20/2002CA2431406A1 Quinazolinone derivatives
06/19/2002EP1215213A2 Bicyclic amino-pyrazone derivatives, their preparation and pharmaceutical compositions containing them
06/19/2002EP1215211A1 Process for the preparation of triethylenediamine
06/19/2002EP1215199A1 Linker molecules for selective metallisation of nucleic acids and their uses
06/19/2002EP1214323A1 Indoloazepines as vasopressin receptor antagonists
06/19/2002EP1214075A1 POLYMORPHS OF N-METHYL-N-(3- 3- 2-THIENYLCARBONYL]-PYRAZOL- 1,5-$g(a)]-PYRIMIDIN-7-YL PHENYL)ACETAMIDE AND COMPOSITIONS AND METHODS RELATED THERETO
06/19/2002EP1214062A2 Method of treating dry eye disease with nicotinic acetylcholine receptor agonists
06/19/2002EP0929609B1 Substituted phthalocyanines and their use
06/19/2002EP0892942B1 layered medium and method for creating a pattern
06/19/2002CN1354174A Synthesis of triethylene diamine and piperazine by using modified zeolite catalyst
06/19/2002CN1086386C Multi-drug resistance modifier
06/18/2002US6407260 Direct dyes; dyeing keratin fibers
06/18/2002US6407259 Process for the preparation of pyrazoles
06/18/2002US6407244 Antiproliferative agent
06/18/2002US6407236 Tumor diagnosis; antiinflammatory agents; antiischemic agents; antidepressants
06/18/2002US6407114 Pyrazolopyrimidinone CGMP PDE5 inhibitors for the treatment of sexual dysfunction
06/18/2002US6407108 1,2,4-triazolo(4,3-b)pyrido(3,2-d)pyridazine derivatives and pharmaceutical compositions containing them
06/18/2002US6407104 Pyrrolo[1,2-a]pyrazine spla2 inhibitor
06/18/2002US6407102 Indole derivatives and their use for the treatment of malignant and other diseases based on pathological cell proliferation
06/18/2002US6407092 Tetracyclic azepinoindole compounds
06/18/2002CA2241725C Growth-hormone secretagogues
06/18/2002CA2057786C Amino and nitro containing tricyclic compounds useful as inhibitors or ace
06/13/2002WO2002046197A1 Macroheterocylic compounds useful as kinase inhibitors
06/13/2002WO2002046195A1 Fungicidal 6-(trifluoromethyl-phenyl)-triazolopyrimidines
06/13/2002WO2002046170A2 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto
06/13/2002WO2002046167A1 Benzyl (idene)-lactams and their use as 5ht1-receptor ligands
06/13/2002WO2002045716A1 Use of pyrazolo[4,3-d]pyrimidines
06/13/2002WO2002045652A2 Tyrosine kinase inhibitors
06/13/2002WO2002024701A3 Substituted azepino[4,5b)indole derivatives
06/13/2002WO2002024700A3 SUBSTITUTED AZEPINO[4,5b]INDOLINE DERIVATIVES
06/13/2002WO2002024686A3 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives
06/13/2002WO2002012245A3 Azabicyclic derivatives and their therapeutic use
06/13/2002WO2002012244A3 Polymorphs of zaleplon and methods for the preparation thereof
06/13/2002WO2002006286A3 IMIDAZO[1,2-a]PYRAZINES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
06/13/2002WO2002004453A3 PYRROLO[3,4-d]PYRIMIDINES AS CORTICOTROPIN RELEASING FACTOR (CRF) ANTAGONISTS
06/13/2002WO2002004442A9 Azabicyclic compounds as inhibitors of nicotinic cholinergic receptors
06/13/2002WO2002000657A3 Condensed pyrazindione derivatives
06/13/2002US20020072615 Useful as intermediate in the preparation of certain small molecules that are useful in therapy or prophylaxis of inflammatory and immune cell-mediated disease
06/13/2002US20020072610 Useful as an intermediate in the preparation of certain small molecules that are useful in therapy or prophylaxis of inflammatory and immune cell-mediated diseases
06/13/2002US20020072605 Reacting N-(3-(3-(dimethylamine)-oxo-2-propenyl)phenyl) acetamide with ethyl iodide in the presence of sodium hydride in dimethylformamide; diluting (N-(3-(3-(dimethylamine)-1-oxo-2-propenyl)acetamide
06/13/2002US20020072604 For prophylaxis and therapy of obesity, diabetes, sexual disorders, eating disorder; for modulating appetite and metabolic rates; for stimulating appetite of livestock for treatment of ketosis, postpartum anestrus
06/13/2002US20020072527 Polymorphs of zaleplon and methods for the preparation thereof
06/13/2002US20020072523 For therapy of inflammatory and immune diseases
06/13/2002US20020072519 Useful as psychotherapeutic agents
06/13/2002US20020072515 For therapy and prophylaxis of ischemic heart diseases such as angina pectoris, arrhythmia, myocardial infarction, congestive heart failure, cerebral infarction and cerebral sequelae after subarachnoid hemorrhage, hypertension
06/13/2002US20020072467 Comprising an amorphous silica binder and crystalline aluminosilicate, e.g. zeolite ZSM-5 having an oxygen ten-membered ring structure; hardness; efficiency; high strength; durability; mixing and molding
06/13/2002US20020072069 Joining particle for use as diagnostic tools in genetic and chemical analysis
06/13/2002DE10061863A1 Preparation of triethylenediamine, useful for making pharmaceuticals and polymers, by reacting ethylenediamine over specific zeolite catalyst